BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6235771)

  • 1. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.
    Argov Z; Navon R
    Ann Neurol; 1984 Jul; 16(1):14-20. PubMed ID: 6235771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexosaminidase A deficiency in adults.
    Navon R; Argov Z; Frisch A
    Am J Med Genet; 1986 May; 24(1):179-96. PubMed ID: 2939718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems].
    Le Coz P; Assouline E; Vanier MT; Goutières F; Mikol J; Woimant F; Pinard JM; Aicardi J; Haguenau M
    Rev Neurol (Paris); 1994; 150(1):61-6. PubMed ID: 7801043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration.
    Mitsumoto H; Sliman RJ; Schafer IA; Sternick CS; Kaufman B; Wilbourn A; Horwitz SJ
    Ann Neurol; 1985 Apr; 17(4):378-85. PubMed ID: 3159334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of hexosaminidase A variant alleles among Ashkenazi Jews and prenatal diagnosis of GM2 gangliosidosis.
    Navon R; Adam A
    Am J Hum Genet; 1985 Sep; 37(5):1031-3. PubMed ID: 2931975
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity.
    Specola N; Vanier MT; Goutières F; Mikol J; Aicardi J
    Neurology; 1990 Jan; 40(1):145-50. PubMed ID: 2136940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-hexosaminidase isozymes and replacement therapy in Gm2 gangliosidosis.
    Rattazzi MC
    Isozymes Curr Top Biol Med Res; 1983; 11():65-81. PubMed ID: 6227586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study.
    Cashman NR; Antel JP; Hancock LW; Dawson G; Horwitz AL; Johnson WG; Huttenlocher PR; Wollmann RL
    Ann Neurol; 1986 Jun; 19(6):568-72. PubMed ID: 3014997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases.
    Willner JP; Grabowski GA; Gordon RE; Bender AN; Desnick RJ
    Neurology; 1981 Jul; 31(7):787-98. PubMed ID: 6454083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult form of GM2-gangliosidosis: a man and 2 sisters with hexosaminidase-A and -B deficiency (Sandhoff disease) and literature review].
    Schnorf H; Bosshard NU; Gitzelmann R; Spycher MA; Isler P; Waespe W
    Schweiz Med Wochenschr; 1996 May; 126(18):757-64. PubMed ID: 8693300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
    Charrow J; Inui K; Wenger DA
    Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant.
    Casal JA; Pérez LF; Tutor JC
    Am J Clin Pathol; 2003 May; 119(5):684-8. PubMed ID: 12760286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
    Buchalter MS; Wannmacher CM; Wajner M
    J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two abnormalities of hexosaminidase A in clinically normal individuals.
    Grebner EE; Mansfield DA; Raghavan SS; Kolodny EH; d'Azzo A; Neufeld EF; Jackson LG
    Am J Hum Genet; 1986 Apr; 38(4):505-14. PubMed ID: 2939713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
    Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
    Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset GM2 gangliosidosis diagnosed in a fetus.
    Navon R; Sandbank U; Frisch A; Baram D; Adam A
    Prenat Diagn; 1986; 6(3):169-76. PubMed ID: 2941730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B1 variant of GM2 gangliosidosis in a 12-year-old patient.
    Goebel HH; Stolte G; Kustermann-Kuhn B; Harzer K
    Pediatr Res; 1989 Jan; 25(1):89-93. PubMed ID: 2521932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatofocusing coupled with automated assay for beta-hexosaminidase isoenzymes in GM2 gangliosidosis.
    Orlacchio A; Maffei C; Emiliani C; Coppa GV; Felici L
    Experientia; 1985 Apr; 41(4):525-7. PubMed ID: 3157597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile spinal muscular atrophy: a new hexosaminidase deficiency phenotype.
    Johnson WG; Wigger HJ; Karp HR; Glaubiger LM; Rowland LP
    Ann Neurol; 1982 Jan; 11(1):11-6. PubMed ID: 6460466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.